Literature DB >> 17135385

Nabilone could treat chorea and irritability in Huntington's disease.

Adrienne Curtis, Hugh Rickards.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17135385     DOI： 10.1176/jnp.2006.18.4.553

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN： 0895-0172            Impact factor:   2.198


× No keyword cloud information.
  18 in total

Review 1.  Cannabis in the Treatment of Dystonia, Dyskinesias, and Tics.

Authors:  Barbara S Koppel
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

2.  Neuroprotective properties of cannabigerol in Huntington's disease: studies in R6/2 mice and 3-nitropropionate-lesioned mice.

Authors:  Sara Valdeolivas; Carmen Navarrete; Irene Cantarero; María L Bellido; Eduardo Muñoz; Onintza Sagredo
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

3.  A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease.

Authors:  Jose Luis López-Sendón Moreno; Juan García Caldentey; Patricia Trigo Cubillo; Carolina Ruiz Romero; Guillermo García Ribas; M A Alonso Alonso Arias; María Jesús García de Yébenes; Rosa María Tolón; Ismael Galve-Roperh; Onintza Sagredo; Sara Valdeolivas; Eva Resel; Silvia Ortega-Gutierrez; María Laura García-Bermejo; Javier Fernández Ruiz; Manuel Guzmán; Justo García de Yébenes Prous
Journal:  J Neurol       Date:  2016-05-09       Impact factor: 4.849

Review 4.  Endocannabinoid system in neurodegenerative disorders.

Authors:  Balapal S Basavarajappa; Madhu Shivakumar; Vikram Joshi; Shivakumar Subbanna
Journal:  J Neurochem       Date:  2017-07-05       Impact factor: 5.372

Review 5.  Therapy development in Huntington disease: From current strategies to emerging opportunities.

Authors:  Audrey S Dickey; Albert R La Spada
Journal:  Am J Med Genet A       Date:  2017-12-08       Impact factor: 2.802

Review 6.  The therapeutic potential of cannabinoids for movement disorders.

Authors:  Benzi Kluger; Piera Triolo; Wallace Jones; Joseph Jankovic
Journal:  Mov Disord       Date:  2015-02-04       Impact factor: 10.338

Review 7.  Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe?

Authors:  Shokouh Arjmand; Zohreh Vaziri; Mina Behzadi; Hassan Abbassian; Gary J Stephens; Mohammad Shabani
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

Review 8.  Treatment of Huntington's disease.

Authors:  Samuel Frank
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 9.  Advances in the pharmacological management of Huntington's disease.

Authors:  Samuel Frank; Joseph Jankovic
Journal:  Drugs       Date:  2010-03-26       Impact factor: 9.546

10.  Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington's disease: role of CB1 and CB2 receptors.

Authors:  Sara Valdeolivas; Valentina Satta; Roger G Pertwee; Javier Fernández-Ruiz; Onintza Sagredo
Journal:  ACS Chem Neurosci       Date:  2012-02-09       Impact factor: 4.418
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.